< Back to companies

ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). Company is founded in early 2019 by four committed founders with a long history in respiratory medicine, medical devices and artificial intelligence. Working on a junction of multidisciplinary fields, founders identified opportunity and value that novel technologies could bring to all parties in a respiratory setting: patients, doctors, healthcare system and industry. ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With the first developed artificial intelligence-based medical software, ArtiQ is already helping interpretation of pulmonary function tests and improving lung disease diagnostic environment.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2019
Website
www.artiq.eu/

Categories

AI / MLDiagnosticsMedical DevicesPulmonary/ Asthma
Only accessible to MedStartr community members. Join now

What do you think of ArtiQ?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now